Ventripoint Diagnostics raised $700K

What does Ventripoint Diagnostics do?

Ventripoint Diagnostics, is a public firm which is devoted to making heart analyzing  more favorable and less costly using techniques based on knowledge. It has installed multiple Angelo(VMS) analysis systems for the right heart in leading heart centers in Canada, Europe and USA and now it’s time for enabling plenty more centers and for expanding the applications beyond congenital heart disease in children and adults. The Angelo’s (VMS)  2D ultrasound imaging removes all the inconveniences of an MRI scan- a long wait, claustrophobia, 1 hour scan time, the necessity of general anesthesia for kids, a long heart analysis process and the necessity for a 2nd trip to the hospital.

How much Ventripoint Diagnostics was funded?

Ventripoint Diagnostics raised $700k in Post Ipo Equity on May 28, 2015.

Previous funding

$138.2k in Venture round on April 1, 2010

$97.7k in Venture round on October 18, 2010

$1.5M in Venture round on January 4, 2011

$1.2M in Venture round on June 17, 2011

$264.6k in Venture round on May 15, 2012

$748k in Debt Financing on May 24, 2013

$250k in Post Ipo Debt on March 26, 2015

What is next for Ventripoint Diagnostics?

The latest funding raised will be used to incur expenditures for the product and service  commercialization of the VMS heart analysis system, for general working capital purpose and potentially to repay debt and outstanding payables.

More about Ventripoint Diagnostics

Ventripoint Diagnostics was founded by Florence H. Sheehan. It has its headquarters in Seattle, WA. It has created diagnostic tools for monitoring patients with cardiac diseases, a leading cause of death n many developed countries. Its VMS is the first cost effective and accurate diagnostic tool to measure the right ventricle heart function. It has many applications for all major heart diseases and imaging modalities which includes congenital heart disease, right or left heart failure and normal hearts.